Behavioral
hypercapnia
hypercapnia is a behavioral intervention with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 33.3%.
Total Trials
4
Max Phase
—
Type
BEHAVIORAL
Molecule
—
Success Metrics
Clinical Success Rate
33.3%
Based on 1 completed trials
Completion Rate
33%(1/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Terminated
2(50%)
Phase Distribution
Ph not_applicable
3
75%
Ph phase_2
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(1)
Terminated(2)
Detailed Status
Terminated2
Recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
33.3%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (25.0%)
N/A3 (75.0%)
Trials by Status
recruiting125%
completed125%
terminated250%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_2
CO2 Modulation in Endovascular Thrombectomy for Acute Ischemic Stroke
NCT05051397
terminatednot_applicable
Exercise in Adolescents With Insulin Resistance
NCT04154865
terminatednot_applicable
Physiological Disturbances Associated With Neonatal Intraventricular Hemorrhage
NCT00665769
completednot_applicable
Hypercapnia During Shoulder Arthroscopy
NCT02643030
Clinical Trials (4)
Showing 4 of 4 trials
NCT05051397Phase 2
CO2 Modulation in Endovascular Thrombectomy for Acute Ischemic Stroke
NCT04154865Not Applicable
Exercise in Adolescents With Insulin Resistance
NCT00665769Not Applicable
Physiological Disturbances Associated With Neonatal Intraventricular Hemorrhage
NCT02643030Not Applicable
Hypercapnia During Shoulder Arthroscopy
All 4 trials loaded
Drug Details
- Intervention Type
- BEHAVIORAL
- Total Trials
- 4